125 related articles for article (PubMed ID: 33908260)
1. Differential expression of sputum and serum autoantibodies in patients with chronic obstructive pulmonary disease.
Cass SP; Dvorkin-Gheva A; Yang Y; McGrath JJC; Thayaparan D; Xiao J; Wang F; Mukherjee M; Long F; Peng T; Nair P; Liang Z; Stevenson CS; Li QZ; Chen R; Stampfli MR
Am J Physiol Lung Cell Mol Physiol; 2021 Jun; 320(6):L1169-L1182. PubMed ID: 33908260
[TBL] [Abstract][Full Text] [Related]
2. Reproducibility of fluid-phase measurements in PBS-treated sputum supernatant of healthy and stable COPD subjects.
Wang F; Liang Z; Yang Y; Zhou L; Guan L; Wu W; Jiang M; Shi W; Deng K; Chen J; Chen R
Int J Chron Obstruct Pulmon Dis; 2019; 14():835-852. PubMed ID: 31043775
[TBL] [Abstract][Full Text] [Related]
3. Increased Circulating Autoantibodies Levels of IgG, IgA, IgM Against Cytokeratin 18 and Cytokeratin 19 in Chronic Obstructive Pulmonary Disease.
Xiong Y; Gao S; Luo G; Cheng G; Huang W; Jiang R; Wang Y; Cui T
Arch Med Res; 2017 Jan; 48(1):79-87. PubMed ID: 28577873
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease?
Rovina N; Papapetropoulos A; Kollintza A; Michailidou M; Simoes DC; Roussos C; Gratziou C
Respir Res; 2007 Jul; 8(1):53. PubMed ID: 17631682
[TBL] [Abstract][Full Text] [Related]
5. Ageing and long-term smoking affects KL-6 levels in the lung, induced sputum and plasma.
Ishikawa N; Mazur W; Toljamo T; Vuopala K; Rönty M; Horimasu Y; Kohno N; Kinnula VL
BMC Pulm Med; 2011 May; 11():22. PubMed ID: 21569324
[TBL] [Abstract][Full Text] [Related]
6. Antibodies of IgG, IgA and IgM against Human Bronchial Epithelial Cell in Patients with Chronic Obstructive Pulmonary Disease.
Cheng G; Zhang N; Wang Y; Rui J; Yin X; Cui T
Clin Lab; 2016; 62(6):1101-8. PubMed ID: 27468572
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies of IgM and IgG classes show differences in recognition of multiple autoantigens in chronic obstructive pulmonary disease.
Shindi R; Almehairi A; Negm OH; Kalsheker N; Gale NS; Shale DJ; Harrison TW; Bolton CE; John M; Todd I; Tighe PJ; Fairclough LC
Clin Immunol; 2017 Oct; 183():344-353. PubMed ID: 28951328
[TBL] [Abstract][Full Text] [Related]
8. Serum Levels of Autoantibodies Against Extracellular Antigens and Neutrophil Granule Proteins Increase in Patients with COPD Compared to Non-COPD Smokers.
Ma A; Wen L; Yin J; Hu Y; Yue X; Li J; Dong X; Gupta Y; Ludwig RJ; Krauss-Etschmann S; Riemekasten G; Petersen F; Yu X
Int J Chron Obstruct Pulmon Dis; 2020; 15():189-200. PubMed ID: 32099344
[TBL] [Abstract][Full Text] [Related]
9. Levels of IL-32 in Serum, Induced Sputum Supernatant, and Bronchial Lavage Fluid of Patients with Chronic Obstructive Pulmonary Disease.
Gasiuniene E; Lavinskiene S; Sakalauskas R; Sitkauskiene B
COPD; 2016 Oct; 13(5):569-75. PubMed ID: 27018873
[TBL] [Abstract][Full Text] [Related]
10. Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients.
Zhang L; Cheng Z; Liu W; Wu K
COPD; 2013 Aug; 10(4):459-65. PubMed ID: 23537276
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease.
Van Pottelberge GR; Mestdagh P; Bracke KR; Thas O; van Durme YM; Joos GF; Vandesompele J; Brusselle GG
Am J Respir Crit Care Med; 2011 Apr; 183(7):898-906. PubMed ID: 21037022
[TBL] [Abstract][Full Text] [Related]
12. 8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD.
Kinnula VL; Ilumets H; Myllärniemi M; Sovijärvi A; Rytilä P
Eur Respir J; 2007 Jan; 29(1):51-5. PubMed ID: 17050565
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of chitotriosidase and YKL-40 in peripheral blood and sputum of healthy smokers and patients with chronic obstructive pulmonary disease.
Majewski S; Tworek D; Szewczyk K; Kiszałkiewicz J; Kurmanowska Z; Brzeziańska-Lasota E; Jerczyńska H; Antczak A; Piotrowski WJ; Górski P
Int J Chron Obstruct Pulmon Dis; 2019; 14():1611-1631. PubMed ID: 31413557
[TBL] [Abstract][Full Text] [Related]
14. Distribution and levels of alpha-1-antitrypsin in the lung and plasma in smokers and chronic obstructive pulmonary disease.
Linja-aho A; Mazur W; Toljamo T; Nieminen P; Ohlmeier S; Rönty M; Kinnula VL
APMIS; 2013 Jan; 121(1):11-21. PubMed ID: 23030783
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies in patients with chronic obstructive pulmonary disease.
Feghali-Bostwick CA; Gadgil AS; Otterbein LE; Pilewski JM; Stoner MW; Csizmadia E; Zhang Y; Sciurba FC; Duncan SR
Am J Respir Crit Care Med; 2008 Jan; 177(2):156-63. PubMed ID: 17975205
[TBL] [Abstract][Full Text] [Related]
16. Alterations in the sputum proteome and transcriptome in smokers and early-stage COPD subjects.
Titz B; Sewer A; Schneider T; Elamin A; Martin F; Dijon S; Luettich K; Guedj E; Vuillaume G; Ivanov NV; Peck MJ; Chaudhary NI; Hoeng J; Peitsch MC
J Proteomics; 2015 Oct; 128():306-20. PubMed ID: 26306861
[TBL] [Abstract][Full Text] [Related]
17. Untargeted lipidomic analysis in chronic obstructive pulmonary disease. Uncovering sphingolipids.
Telenga ED; Hoffmann RF; Ruben t'Kindt ; Hoonhorst SJ; Willemse BW; van Oosterhout AJ; Heijink IH; van den Berge M; Jorge L; Sandra P; Postma DS; Sandra K; ten Hacken NH
Am J Respir Crit Care Med; 2014 Jul; 190(2):155-64. PubMed ID: 24871890
[TBL] [Abstract][Full Text] [Related]
18. Potential prognostic value of biomarkers in lavage, sputum and serum in a five year clinical follow-up of smokers with and without COPD.
Holz O; Waschki B; Roepcke S; Watz H; Lauer G; Faulenbach C; Hohlfeld JM
BMC Pulm Med; 2014 Mar; 14():30. PubMed ID: 24581181
[TBL] [Abstract][Full Text] [Related]
19. Modulation of glutaredoxin in the lung and sputum of cigarette smokers and chronic obstructive pulmonary disease.
Peltoniemi MJ; Rytilä PH; Harju TH; Soini YM; Salmenkivi KM; Ruddock LW; Kinnula VL
Respir Res; 2006 Oct; 7(1):133. PubMed ID: 17064412
[TBL] [Abstract][Full Text] [Related]
20. Natural and disease-specific autoantibodies in chronic obstructive pulmonary disease.
Daffa NI; Tighe PJ; Corne JM; Fairclough LC; Todd I
Clin Exp Immunol; 2015 Apr; 180(1):155-63. PubMed ID: 25469980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
